KRRO Korro Bio, Inc.

P/E --
Forward P/E --
Price/Sales 80.8
Beta 2.213
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 Korro Bio is trading 6.2% down today amid ongoing post-trial volatility

Korro Bio is trading 6.2% down today at $13.41 amid ongoing post-trial volatility, with no new company-specific headlines emerging. • Shares remain pressured...

🟢 KRRO is trading 5.1% up today, extending its multi-session rebound despite no fresh catalysts

KRRO is trading 5.1% up at $14.77, extending its strong multi-session rebound over the past week. • The stock's gains come as broader U.S. indices trade lower...

🟢 KRRO is trading 5.5% up today on bullish analyst ratings and RNA-editing pipeline optimism

KRRO is trading 5.5% up at $13.39 as traders extend a recent rebound fueled by bullish analyst price targets and strong Buy ratings. • The move builds on...

🟢 KRRO is trading 5.1% up today on bullish analyst upgrades and rising price targets

KRRO is trading 5.1% up at $12.79 as investors react to a series of bullish analyst upgrades and rising price targets for the biotech firm. • The stock is...

Korro Bio Rides a Wave of Analyst Upgrades, but Can a Pre-Revenue Biotech Justify the Hype?

Korro Bio Rides a Wave of Analyst Upgrades, but Can a Pre-Revenue Biotech Justify the Hype?

Shares surged 12.5% to $13.69 in pre-market trading Thursday as investors continued to reprice Korro Bio around a string of Wall Street upgrades that have...

🟢 KRRO is trading 12.5% up today as analyst upgrades raise price targets to $30

KRRO is trading 12.5% up at $13.69 in pre-market action after a string of analyst upgrades this year raised price targets as high as $30, significantly...

🔴 KRRO makes sharp 10.5% drop

KRRO is trading at $12.32, down 10.5% versus the comparison close of $13.77 during regular trading. This is a price-movement alert; no separate...

🔴 KRRO drops 7.04% on profit-taking, director share sales, amidst pipeline updates and analyst rating changes

• KRRO is trading 7.04% down today at $12.80, reversing from a sharp multi-day rally. • This decline follows director share sales reported on June 23 and...

🟢 KRRO is trading 5.4% up today as multi-day rally continues

KRRO is trading at $14.45 (5.4% up) as the speculative small-cap biotech extends its strong multi-day rally from mid-June. • The move appears driven by...

🔴 KRRO is trading 5.1% down today as it gives back recent gains

KRRO is trading 5.1% down at $13.01 in pre-market, giving back part of its sharp gains from a strong multi-day rally between June 18 and June 22. • The move...

🟢 KRRO is trading 5% up today extending multi-day rally

KRRO is trading 5% up today at $13.64, extending a strong multi-day rally from recent lows despite a lack of fresh company-specific headlines or filings. •...

🟢 Korro Bio, Inc. is trading 7.8% up today following a bullish Jones Trading upgrade and positive pipeline updates

• Korro Bio, Inc. is trading at $14.00 (7.8% up) in after-hours trading. • The stock gained 17.56% during the regular session on June 18, 2026, driven by...

Korro Bio Surges 10% on a Wall Street Upgrade, but Can RNA Editing Promises Survive the Long Road to Human Trials?

Korro Bio Surges 10% on a Wall Street Upgrade, but Can RNA Editing Promises Survive the Long Road to Human Trials?

Shares of Korro Bio jumped 10.4% to $12.20 on June 18 after Jones Trading upgraded the stock from Hold to Buy, slapping a $23.00 price target that implies...

🟢 Korro Bio, Inc. is trading 10.36% up today after Jones Trading upgrade and positive RNA editing data

Korro Bio, Inc. is trading at $12.20 (+10.36%) today following a Jones Trading upgrade to Buy and reports of promising preclinical RNA editing data. • Jones...

🟢 Korro Bio, Inc. is trading 7.3% up today following analyst upgrade and promising preclinical data

Korro Bio, Inc. is trading at $11.85 (+7.27%) in pre-market. • Jones Trading upgraded Korro Bio to Buy with a price target of $23.00 after reporting promising...